
# Title 42 - Public Health
## Chapter I - Public Health Service, Department of Health and Human Services
### Subchapter A - General Provisions
#### PART 11 - CLINICAL TRIALS REGISTRATION AND RESULTS INFORMATION SUBMISSION
##### Subpart B - Registration
###### ยง 11.35 By when will the NIH Director post clinical trial registration information submitted under ยง 11.28?
####### ClinicalTrials.gov

(i) The Director will post publicly onthe clinical trial registration information, except for certain administrative data, not earlier than the date of FDA approval or clearance of the device product and not later than 30 calendar days after the date of such approval or clearance, except as otherwise provided in paragraph (b)(2)(ii) of this section.

(ii) If, prior to the date of approval or clearance of the device product, the responsible party for an applicable clinical trial that is initiated on or after January 18, 2017, indicates to the Director, by submitting the Post Prior to U.S. FDA Approval or Clearance data element under ยง 11.28(a)(2)(i)(Q), that it is authorizing the Director to publicly post its clinical trial registration information, which would otherwise be subject to delayed posting as specified in paragraph (b)(2)(i) of this section, prior to the date of FDA approval or clearance of its device product, the Director will publicly post the registration information, except for certain administrative data, as soon as practicable.
